Kazia Therapeutics (KZIA) Total Debt (2011 - 2025)

Kazia Therapeutics has reported Total Debt for 6 years, with the latest figure at $9.3 million in Q4 2025.

• For the quarter ending Q4 2025, Total Debt rose 605.56% year-over-year to $9.3 million; the trailing twelve-month figure through Dec 2025 stood at $9.3 million (up 605.56% YoY), and the FY2025 full-year result was $2.0 million, down 52.74% from the prior year.
• Total Debt for Q4 2025 stood at $9.3 million, up from $2.0 million in the prior quarter.
• The five-year high for Total Debt was $9.3 million in Q4 2025, with the low at -$1.3 million in Q2 2022.
• Historically, Total Debt has averaged $3.8 million across 4 years, with a median of $4.3 million in 2024.
• Annual changes were most pronounced in 2024 — Total Debt slumped 76.43% — and 2025, when it surged 605.56%.
• Kazia Therapeutics' Total Debt stood at -$1.3 million in 2022, then soared by 524.56% to $5.6 million in 2023, then slumped by 76.43% to $1.3 million in 2024, then surged by 605.56% to $9.3 million in 2025.
• The last three Total Debt figures came in at $9.3 million (Q4 2025), $2.0 million (Q2 2025), and $1.3 million (Q4 2024), per Business Quant data.